Cargando…
Berberine Ameliorates Diabetes-Associated Cognitive Decline through Modulation of Aberrant Inflammation Response and Insulin Signaling Pathway in DM Rats
Background: Memory-impairment was one of the common characteristics in patients with diabetes mellitus. The release of chronic inflammation mediators and insulin resistance in diabetic brain gave rise to the generation of toxic factor Aβ42 which was the marker of Alzheimer’s disease. In addition, th...
Autores principales: | Chen, Qingjie, Mo, Ran, Wu, Ninghua, Zou, Xin, Shi, Cai, Gong, Jing, Li, Jingbin, Fang, Ke, Wang, Dingkun, Yang, Deshen, Wang, Kaifu, Chen, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460072/ https://www.ncbi.nlm.nih.gov/pubmed/28634451 http://dx.doi.org/10.3389/fphar.2017.00334 |
Ejemplares similares
-
Berberine Ameliorates Spatial Learning Memory Impairment and Modulates Cholinergic Anti-Inflammatory Pathway in Diabetic Rats
por: Wang, Kaifu, et al.
Publicado: (2019) -
Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats
por: Gong, Jing, et al.
Publicado: (2017) -
Berberine Reduces Aβ(42) Deposition and Tau Hyperphosphorylation via Ameliorating Endoplasmic Reticulum Stress
por: Wu, Yue, et al.
Publicado: (2021) -
Berberine Alleviates Insulin Resistance and Inflammation via Inhibiting the LTB4–BLT1 Axis
por: Gong, Minmin, et al.
Publicado: (2021) -
Efficacy and Safety of Berberine Alone for Several Metabolic Disorders: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Ye, Yu, et al.
Publicado: (2021)